<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107471">
         <dct:format>application/xml</dct:format>
         <dct:title>Dataset of human EDEM2 melanoma cells proteomics, affinity proteomics and
                deglycoproteomics</dct:title>
         <dct:creator>Gabriela N. Chirițoiu</dct:creator>
         <dct:creator>Marioara Chirițoiu</dct:creator>
         <dct:creator>Cristian V.A. Munteanu</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Endoplasmic reticulum associated degradation (ERAD)</rdf:li>
               <rdf:li>Stable isotope labeling by amino acids in cell culture (SILAC)</rdf:li>
               <rdf:li>Cancer</rdf:li>
               <rdf:li>Mass spectrometry</rdf:li>
               <rdf:li>liquid chromatography</rdf:li>
               <rdf:li>ITGA1</rdf:li>
               <rdf:li>Tyrosinase</rdf:li>
               <rdf:li>Proteasome</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>Data in Brief 39 (2021).
                doi:10.1016/j.dib.2021.107471</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Data in Brief</prism:publicationName>
         <prism:copyright>© 2021 The Author(s). Published by Elsevier Inc.</prism:copyright>
         <dct:publisher>Elsevier Inc.</dct:publisher>
         <prism:issn>2352-3409</prism:issn>
         <prism:volume>39</prism:volume>
         <prism:coverDisplayDate>December 2021</prism:coverDisplayDate>
         <prism:doi>10.1016/j.dib.2021.107471</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.dib.2021.107471</prism:url>
         <dct:identifier>doi:10.1016/j.dib.2021.107471</dct:identifier>
         <bam:articleNumber>107471</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-10-06T01:43:54Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open
                access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S300.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="dat" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>DIB</ja:jid>
         <ja:aid>107471</ja:aid>
         <ce:article-number>107471</ce:article-number>
         <ce:pii>S2352-3409(21)00737-X</ce:pii>
         <ce:doi>10.1016/j.dib.2021.107471</ce:doi>
         <ce:copyright type="unknown" year="2021"/>
      </ja:item-info>
      <ja:head>
         <ce:dochead id="dchd0001">
            <ce:textfn id="dhtxt0001">Data Article</ce:textfn>
         </ce:dochead>
         <ce:title id="tte0002">Dataset of human EDEM2 melanoma cells proteomics, affinity
                proteomics and deglycoproteomics</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S235234092100737X-e67b1227383cbe5495877c647cfbef59">
               <ce:given-name>Gabriela N.</ce:given-name>
               <ce:surname>Chirițoiu</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ea3"
                             type="social-media"
                             xlink:href="https://twitter.com/GabiNChiritoiu">@GabiNChiritoiu</ce:e-address>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S235234092100737X-486b81f9f826504215fb6df989f62102"
                       orcid="0000-0003-2064-2003">
               <ce:given-name>Marioara</ce:given-name>
               <ce:surname>Chirițoiu</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ea3a"
                             type="social-media"
                             xlink:href="https://twitter.com/ChiritoiuMari">@ChiritoiuMari</ce:e-address>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S235234092100737X-28a89e12af85ca1996b11124632e7105"
                       orcid="0000-0002-2998-0458">
               <ce:given-name>Cristian V.A.</ce:given-name>
               <ce:surname>Munteanu</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001"
                             type="email"
                             xlink:href="mailto:cristian.munteanu@biochim.ro">cristian.munteanu@biochim.ro</ce:e-address>
               <ce:e-address id="ea3b"
                             type="social-media"
                             xlink:href="https://twitter.com/CristiVMunteanu">@CristiVMunteanu</ce:e-address>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S235234092100737X-a87d8bb6a6b4e6373b69b0d1b3314db2">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">Department of Molecular Cell Biology, Institute of
                        Biochemistry, Splaiul Independenței 296, Bucharest 060031,
                        Romania</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Molecular Cell Biology</sa:organization>
                  <sa:organization>Institute of Biochemistry</sa:organization>
                  <sa:address-line>Splaiul Independenței 296</sa:address-line>
                  <sa:city>Bucharest</sa:city>
                  <sa:postal-code>060031</sa:postal-code>
                  <sa:country>Romania</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aDepartment of Molecular Cell Biology, Institute
                        of Biochemistry, Splaiul Independenței 296, Bucharest 060031,
                        Romania</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S235234092100737X-ecae40dc050f1ee2a7718ad9c72be5c7">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">Department of Bioinformatics and Structural
                        Biochemistry, Institute of Biochemistry, Splaiul Independenței 296,
                        Bucharest 060031, Romania</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Bioinformatics and Structural
                            Biochemistry</sa:organization>
                  <sa:organization>Institute of Biochemistry</sa:organization>
                  <sa:address-line>Splaiul Independenței 296</sa:address-line>
                  <sa:city>Bucharest</sa:city>
                  <sa:postal-code>060031</sa:postal-code>
                  <sa:country>Romania</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bDepartment of Bioinformatics and Structural
                        Biochemistry, Institute of Biochemistry, Splaiul Independenței 296,
                        Bucharest 060031, Romania</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding author.</ce:text>
            </ce:correspondence>
         </ce:author-group>
         <ce:date-received day="2" month="9" year="2021"/>
         <ce:date-revised day="2" month="10" year="2021"/>
         <ce:date-accepted day="4" month="10" year="2021"/>
         <ce:abstract id="abs0001" view="all" class="author">
            <ce:section-title id="cesectitle0001">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0001" view="all">
               <ce:simple-para id="spara004" view="all">EDEM2 (Endoplasmic reticulum
                        Degradation-Enhancing alpha-Mannosidase-like protein 2) is one of the
                        key-proteins suggested to be involved in the selection and degradation of
                        misfolded proteins from the endoplasmic reticulum. The datasets discussed in
                        this article are related to experiments covering affinity proteomics,
                        label-free quantitative proteomics, deglycoproteomics and SILAC (Stable
                        Isotope Labeling by Amino Acids in Cell Culture) proteomics data of A375
                        melanoma cells with modified expression of EDEM2. Our first aim was to
                        affinity-enrich EDEM2 alongside its potential interaction partners and
                        analyse the obtained samples by nanoLC-MS/MS to identify novel EDEM2
                        associated proteins. The dataset was substantiated by SDF (Sucrose Density
                        Fractionation)-nanoLC-MS/MS experiments, in an integrated workflow to
                        validate EDEM2 identified partners and corroborate these with previous data.
                        Our second aim was to delineate novel EDEM2 substrate candidates using a
                        two-step strategy. The first one refers to the deglycoproteomics dataset,
                        which covers nanoLC-MS/MS analysis of Concanavalin A enriched glycopeptides
                        released by endoglycosidase digestion from A375 melanoma cell lysates. This
                        allowed us to map the fraction of glycoproteins with non-matured N-glycans
                        from A375 melanoma cells and find or validate
                        <ce:italic>N</ce:italic>-glycosylation sites of proteins from the secretory
                        pathway. The same dataset was also used to define glycoproteins altered by
                        the down-regulation of endogenous EDEM2, which should contain its
                        candidate-substrates. In a second step we delineate the degradation kinetics
                        of some of these proteins using a pulse SILAC strategy (pSILAC) thus
                        complementing our initial findings with a fourth dataset. Beside
                        nanoLC-MS/MS analysis our findings were also validated by various
                        biochemical experiments. All the data described are associated with a
                        research article published in Molecular and Cellular Proteomics
                        [1].</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords id="keys0001" view="all" class="keyword">
            <ce:section-title id="cesectitle0002">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Endoplasmic reticulum associated degradation
                        (ERAD)</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Stable isotope labeling by amino acids in cell culture
                        (SILAC)</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">Cancer</ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">Mass spectrometry</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">liquid chromatography</ce:text>
            </ce:keyword>
            <ce:keyword id="key0006">
               <ce:text id="cetext0007">ITGA1</ce:text>
            </ce:keyword>
            <ce:keyword id="key0007">
               <ce:text id="cetext0008">Tyrosinase</ce:text>
            </ce:keyword>
            <ce:keyword id="key0008">
               <ce:text id="cetext0009">Proteasome</ce:text>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
